RhumbLine Advisers
PLRX icon

RhumbLine Advisers’s Pliant Therapeutics PLRX Stock Holding History

RhumbLine Advisers’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,379
Closed -$3K – 4224
2026
Q1 		$3K Hold
2,379
– – ﹤0.01% 3910
2025
Q4 		$2.9K Hold
2,379
– – ﹤0.01% 3959
2025
Q3 		$3.52K Hold
2,379
– – ﹤0.01% 3940
2025
Q2 		$2.76K Sell
2,379
-87,315
-97% -$123K ﹤0.01% 3967
2025
Q1 		$121K Sell
89,694
-2,886
-3% -$17.5K ﹤0.01% 3319
2024
Q4 		$1.22M Sell
92,580
-2,117
-2% -$28.9K ﹤0.01% 2143
2024
Q3 		$1.06M Sell
94,697
-1,791
-2% -$22.4K ﹤0.01% 2238
2024
Q2 		$1.04M Buy
96,488
+14,662
+18% +$189K ﹤0.01% 2221
2024
Q1 		$1.22M Buy
81,826
+1,212
+2% +$20K ﹤0.01% 2142
2023
Q4 		$1.46M Buy
80,614
+1,517
+2% +$23.1K ﹤0.01% 2072
2023
Q3 		$1.37M Buy
79,097
+255
+0.3% +$4.42K ﹤0.01% 2038
2023
Q2 		$1.43M Buy
+78,842
New +$1.87M ﹤0.01% 2097
2022
Q2 		– Sell
-22,867
Closed -$160K – 3202
2022
Q1 		$160K Buy
22,867
+523
+2% +$5.34K ﹤0.01% 2802
2021
Q4 		$302K Sell
22,344
-416
-2% -$6.61K ﹤0.01% 2701
2021
Q3 		$384K Buy
22,760
+995
+5% +$21.1K ﹤0.01% 2670
2021
Q2 		$634K Sell
21,765
-2,282
-9% -$71K ﹤0.01% 2448
2021
Q1 		$946K Buy
24,047
+13,798
+135% +$448K ﹤0.01% 2214
2020
Q4 		$233K Buy
+10,249
New +$257K ﹤0.01% 2772

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

RhumbLine Advisers's PLRX Position: Q2 2026 in Review

RhumbLine Advisers sold out of Pliant Therapeutics (PLRX) in Q2 2026, closing a stake of 2,379 shares — an estimated $3K sold.

RhumbLine Advisers first reported a position in PLRX in Q4 2020 and held it in 18 quarters. The position peaked at $1.46M in Q4 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • RhumbLine Advisers reported no remaining Pliant Therapeutics position as of Q2 2026 after selling out during the quarter.
  • RhumbLine Advisers sold 2,379 Pliant Therapeutics shares in Q2 2026, an estimated $3K.
  • RhumbLine Advisers first reported a position in Pliant Therapeutics in Q4 2020 and held it in 18 quarters.
  • RhumbLine Advisers's Pliant Therapeutics position peaked at $1.46M in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.